ADD CONDITION

items per page

Razzmatazz

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Calcium Carbonate 500 mg
Other brand names
Dosage form
Tablet
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
January 14, 2026
Active ingredient
Calcium Carbonate 500 mg
Other brand names
Dosage form
Tablet
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
January 14, 2026
Manufacturer
Wildman Business Group
Registration number
M001
NDC root
84269-2516

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Razzmatazz™ is a raspberry-flavored antacid designed to provide quick relief from common digestive discomforts. It helps alleviate symptoms such as heartburn, sour stomach, acid indigestion, and upset stomach. With its fast-acting formula, Razzmatazz™ aims to soothe your stomach and restore comfort when you need it most.

Uses

If you're experiencing discomfort from heartburn, sour stomach, or acid indigestion, this medication can help provide relief. It is also effective for an upset stomach that comes along with these symptoms.

You can use this medication to ease the discomfort associated with these common digestive issues, allowing you to feel more comfortable throughout your day.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you can take this medication by chewing 2 to 4 tablets whenever you experience symptoms. It's important to follow your doctor's advice regarding the dosage. However, if your symptoms last longer than 2 weeks, you should consult your doctor before continuing to take the medication.

Remember, these chewable tablets are meant to be taken as needed, so you don’t have to take them on a regular schedule. Just chew the tablets when you feel symptoms arise, and make sure to seek medical advice if your condition doesn’t improve.

What to Avoid

It's important to use this medication responsibly to ensure your safety. You should not take more than 15 tablets in a 24-hour period. If you are pregnant, limit your intake to no more than 10 tablets in the same timeframe. Additionally, avoid using the maximum dosage for longer than 2 weeks unless your doctor has advised and is supervising you.

By following these guidelines, you can help prevent potential risks associated with misuse or overuse of the medication. Always consult with your healthcare provider if you have any questions or concerns about your treatment.

Side Effects

It's important to be aware of potential side effects when using this product. You should consult with a doctor or pharmacist before use if you have kidney disease or are taking any prescription medications, as antacids can interact with certain drugs.

While using this product, do not exceed 15 tablets in a 24-hour period, and if you are pregnant, limit your intake to no more than 10 tablets in 24 hours. Additionally, avoid using the maximum dosage for more than two weeks unless directed by a healthcare professional. Always keep this product out of reach of children.

Warnings and Precautions

Before using this product, it’s important to consult with your doctor or pharmacist if you have kidney disease or are taking any prescription medications, as antacids can interact with certain drugs.

While using this product, please remember not to exceed 15 tablets in a 24-hour period. If you are pregnant, limit your intake to no more than 10 tablets in 24 hours. Additionally, avoid using the maximum dosage for more than two weeks unless directed by your doctor.

If you experience any unusual symptoms or have concerns, it’s best to stop using the product and reach out to your healthcare provider for guidance.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it’s important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, you should contact your local emergency services or go to the nearest hospital right away. Always keep the medication packaging on hand, as it can provide important information to healthcare professionals. Remember, it’s better to be safe and get checked out if you have any concerns about an overdose.

Pregnancy Use

If you are pregnant, it’s important to be cautious with medication. You should not take more than 10 tablets in a 24-hour period. Additionally, avoid using the maximum dosage for more than 2 weeks unless your doctor has advised and is supervising you. Always consult with your healthcare provider before taking any medication during pregnancy to ensure the safety of you and your baby.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available regarding the effects of this medication on nursing mothers or lactation (the process of producing breast milk). Since the insert does not provide guidance on these topics, it may be wise to consult your healthcare provider for personalized advice. They can help you understand any potential risks and make informed decisions about your health and your baby's well-being.

Pediatric Use

If you are considering this medication for your child, it's important to note that it is intended for use in children aged 12 years and older. For this age group, the recommended dosage is to chew 2 to 4 tablets when symptoms arise, or as directed by a healthcare professional. Always consult with your child's doctor before starting any new medication to ensure it is appropriate for their specific needs.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney disease, it's important to consult with your doctor or pharmacist before using this medication. They can provide guidance on whether it's safe for you and if any adjustments to your dosage are necessary. Your healthcare team will help ensure that your treatment is both effective and safe, taking your kidney health into account.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to be aware that some over-the-counter medications, such as antacids containing calcium carbonate, can interact with certain prescription drugs. These interactions may affect how well your medications work by altering their absorption in your body.

To ensure your treatment is safe and effective, always discuss any medications you are taking, including over-the-counter products, with your healthcare provider. They can help you understand potential interactions and make any necessary adjustments to your treatment plan.

Storage and Handling

To ensure the safety and effectiveness of your product, store it in a cool, dry place at a temperature between 15º-30ºC (59º-86ºF). This temperature range helps maintain the product's integrity. Always check the packaging before use; if the packet is torn or opened, do not use it, as this indicates that the product may have been tampered with or compromised.

By following these simple storage and handling guidelines, you can help ensure that the product remains safe and effective for your use.

Additional Information

No further information is available.

FAQ

What is Razzmatazz™?

Razzmatazz™ is a raspberry-flavored antacid used for the relief of heartburn, sour stomach, acid indigestion, and upset stomach.

How should I take Razzmatazz™?

Adults and children 12 years and older should chew 2 to 4 tablets as symptoms occur, or as directed by a doctor.

What is the maximum dosage for Razzmatazz™?

Do not take more than 15 tablets in 24 hours, and if pregnant, do not take more than 10 tablets in 24 hours.

Can I use Razzmatazz™ for more than 2 weeks?

You should not use the maximum dosage for more than 2 weeks unless advised by a doctor.

Are there any warnings for using Razzmatazz™?

Yes, ask a doctor or pharmacist before use if you have kidney disease or are taking a prescription drug, as antacids may interact with certain medications.

What should I do if I have symptoms that persist?

If your symptoms persist for more than 2 weeks, consult a doctor.

Is Razzmatazz™ safe to use during pregnancy?

While there are no teratogenic effects mentioned, pregnant individuals should not exceed 10 tablets in 24 hours.

How should I store Razzmatazz™?

Store Razzmatazz™ at 15º-30ºC (59º-86ºF) and do not use if the packet is torn or opened.

What are the indications for using Razzmatazz™?

Razzmatazz™ is indicated for the relief of heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

Is there any specific information for nursing mothers?

There is no specific information provided regarding the use of Razzmatazz™ in nursing mothers.

Packaging Info

Below are the non-prescription pack sizes of Razzmatazz (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Razzmatazz.
Details

Drug Information (PDF)

This file contains official product information for Razzmatazz, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to chew 2 to 4 tablets as symptoms occur, or as directed by a healthcare professional. It is important to note that the medication should not be taken for symptoms that persist for more than 2 weeks unless advised by a doctor.

The chewable tablets are to be administered orally, and they should be taken as needed based on symptom presentation.

Contraindications

There are no specific contraindications identified for this product. However, the following usage instructions should be adhered to in order to ensure safety:

  • The maximum dosage should not exceed 15 tablets within a 24-hour period.

  • For pregnant individuals, the dosage should not exceed 10 tablets in a 24-hour period.

  • The maximum dosage should not be used for more than 2 weeks unless directed and supervised by a healthcare professional.

Warnings and Precautions

Healthcare professionals should exercise caution when recommending this product, particularly in patients with specific health conditions or those on concurrent medications.

Warnings Prior to use, it is imperative for patients to consult with a healthcare provider if they have a history of kidney disease or are currently taking prescription medications, as antacids may interact with certain drugs.

General Precautions When administering this product, it is essential to adhere to the following guidelines:

  • Patients should not exceed a maximum dosage of 15 tablets within a 24-hour period.

  • For pregnant individuals, the dosage should not exceed 10 tablets in a 24-hour period.

  • The maximum dosage should not be utilized for more than 2 weeks unless directed and monitored by a healthcare professional.

No specific laboratory tests are recommended for monitoring the use of this product. However, healthcare providers should remain vigilant for any potential interactions or adverse effects in patients with the aforementioned conditions.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. It is important to consult a healthcare professional before use if there is a history of kidney disease or if the patient is currently taking a prescription medication, as antacids may interact with certain drugs.

When using this product, patients are advised not to exceed 15 tablets within a 24-hour period. For pregnant individuals, the maximum recommended dosage is limited to 10 tablets in 24 hours. Additionally, the maximum dosage should not be used for more than 2 weeks unless under the guidance and supervision of a healthcare provider.

To ensure safety, this product should be kept out of reach of children.

Drug Interactions

Antacids, particularly those containing calcium carbonate, may interact with certain prescription medications, potentially impacting their absorption and overall efficacy. It is advisable for healthcare professionals to monitor patients for any changes in therapeutic effects when these antacids are co-administered with other drugs. Adjustments to the timing of administration or dosage may be necessary to mitigate these interactions.

No additional drug interactions or interactions with laboratory tests have been reported.

Packaging & NDC

Below are the non-prescription pack sizes of Razzmatazz (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Razzmatazz.
Details

Pediatric Use

Pediatric patients aged 12 years and older may chew 2 to 4 tablets as symptoms occur, or as directed by a healthcare professional. There are no specific dosage recommendations for children under 12 years of age. Healthcare providers should exercise caution when considering the use of this medication in younger populations, as safety and efficacy have not been established in this age group.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should not exceed a dosage of 10 tablets within a 24-hour period. Additionally, the maximum dosage should not be used for more than 2 weeks unless under the advice and supervision of a healthcare professional. It is important for healthcare providers to consider these guidelines when prescribing this medication to pregnant patients to minimize potential risks to fetal outcomes.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Consequently, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the potential risks to breastfed infants are not clearly defined. It is advisable to consider the benefits of breastfeeding alongside the unknowns related to the medication's excretion in breast milk and its potential effects on breastfed infants.

Renal Impairment

Patients with renal impairment should consult a healthcare professional, such as a doctor or pharmacist, prior to use. It is essential to assess renal function and consider any necessary dosing adjustments or precautions based on the degree of kidney disease. Monitoring of renal function may be warranted to ensure safe and effective use of the medication in this population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be tailored to the individual patient and may involve supportive care, symptomatic treatment, and, if applicable, the use of specific antidotes. It is crucial to consult local poison control guidelines and the product's prescribing information for detailed management protocols.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution and be prepared to act swiftly in the event of an overdose scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. When using this product, patients should be instructed not to exceed a maximum of 15 tablets within a 24-hour period. For pregnant patients, it is crucial to limit the intake to no more than 10 tablets in a 24-hour period. Additionally, patients should be cautioned against using the maximum dosage for more than 2 weeks unless under the guidance and supervision of a healthcare professional.

Providers should encourage patients to consult with a doctor or pharmacist prior to use if they have a history of kidney disease or if they are currently taking any prescription medications, as antacids may interact with certain drugs. This information is essential for ensuring safe and effective use of the product.

Storage and Handling

The product is supplied in tamper-evident packaging. It is essential to inspect the packet before use; do not utilize the product if the packet is torn or opened.

For optimal storage, the product should be maintained at a temperature range of 15º to 30ºC (59º to 86ºF). Proper handling and storage conditions are crucial to ensure the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Razzmatazz, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Razzmatazz, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.